SCHEMBL2140990

SCHEMBL2140990

CCOc1cc(C)ccc1B(O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.45
L3MBTL1 Q9Y468 4/20 0.45
RAB9A P51151 1/20 0.45
ATM Q13315 1/20 0.45
POLB P06746 4/20 0.41
ALDH1A1 P00352 3/20 0.41
HPGD P15428 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
TSHR P16473 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
KDM4E B2RXH2 3/20 0.41
KCNMA1 Q12791 1/20 0.38
ACHE P22303 1/20 0.38
LIPE Q05469 1/20 0.37
MAPK1 P28482 2/20 0.36
HSD17B10 Q99714 2/20 0.36
HTT P42858 2/20 0.36
GAA P10253 1/20 0.36
AR P10275 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29956763 0.85 MAPT (0.45) MAPTL3MBTL1RAB9AATMPOLB
SCHEMBL1490739 0.85 MAPT (0.45) MAPTL3MBTL1RAB9AATMPOLB
SCHEMBL30995019 0.81 ACHE (0.39) MAPTL3MBTL1RAB9APOLBALDH1A1
SCHEMBL26316395 0.81 ACHE (0.39) MAPTL3MBTL1RAB9APOLBALDH1A1
SCHEMBL3793494 0.81 KDM4E (0.53) MAPTPOLBALDH1A1HPGDTDP1
SCHEMBL29952558 0.81 KDM4E (0.53) MAPTPOLBALDH1A1HPGDTDP1
SCHEMBL2634947 0.80 ALDH1A1 (0.46) MAPTALDH1A1TSHRMEN1KMT2A
SCHEMBL29954551 0.79 L3MBTL1 (0.42) L3MBTL1ALDH1A1HPGDTDP1LIPE
SCHEMBL29952519 0.79 TSHR (0.49) MAPTL3MBTL1RAB9AATMHPGD
SCHEMBL4050099 0.79 L3MBTL1 (0.42) L3MBTL1ALDH1A1HPGDTDP1LIPE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148407-B2 Compounds derived from 5-thioxylose and their use in therapeutics LABORATORIES FOURNIER S.A. (FR) 2012-04-03 US disclosed
US-20080293768-A1 Novel Compounds Derived From 5-Thioxylose And Their Use In Therapeutics INVENTIVA (FR) 2008-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293768-A1 Novel Compounds Derived From 5-Thioxylose And Their Use In Therapeutics TPMT, STS, TBXAS1 MAPT 4772/4885L3MBTL1 1133/4885RAB9A 3218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.